About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
HISTORICAL VOLUME
Historical
Volume
Cohance Lifesciences Ltd.
BSE Code
543064
ISIN Demat
INE03QK01018
Book Value
115.25
NSE Code
COHANCE
Dividend Yield %
0.00
Market Cap
205055.99
P/E
73.88
EPS
7.25
Face Value
1
Exchange :
BSE
NSE
Period From :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2025
2024
Period To :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2025
2024
Date
Open Price(Rs.)
High Price(Rs.)
Low Price(Rs.)
Close Price(Rs.)
Volume
Turnover
23-Dec-2025
547.60
547.60
534.00
536.00
10946
5869071
22-Dec-2025
549.80
549.80
535.00
539.95
8228
4440559
19-Dec-2025
525.05
544.80
525.05
538.05
44788
24064302
18-Dec-2025
525.30
532.20
520.50
530.30
9445
4959576
17-Dec-2025
538.30
540.00
518.00
525.20
22345
11726185
16-Dec-2025
527.35
545.00
527.35
538.15
47921
25800004
15-Dec-2025
525.30
538.00
525.30
530.35
10968
5853543
12-Dec-2025
531.50
541.35
530.00
536.50
19268
10304943
11-Dec-2025
528.25
536.10
522.00
531.20
27218
14414094
10-Dec-2025
538.25
539.25
523.30
528.25
19387
10268782
09-Dec-2025
521.90
537.05
521.45
535.25
23802
12596862
08-Dec-2025
540.05
540.10
525.05
530.70
19851
10526065
05-Dec-2025
543.05
548.20
533.85
542.20
26679
14439639
04-Dec-2025
543.75
551.00
540.50
549.10
15752
8601456
03-Dec-2025
549.05
557.70
541.00
543.55
24058
13180450
02-Dec-2025
553.35
554.30
543.30
546.20
20025
10963160
01-Dec-2025
565.00
569.70
550.50
553.25
17088
9525888
Page
1
of
1
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
|
UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.